1
|
Blumberg S, Prada JM, Tedijanto C, Deiner MS, Godwin WW, Emerson PM, Hooper PJ, Borlase A, Hollingsworth TD, Oldenburg CE, Porco TC, Arnold BF, Lietman TM. Forecasting Trachoma Control and Identifying Transmission-Hotspots. Clin Infect Dis 2021; 72:S134-S139. [PMID: 33905484 PMCID: PMC8201580 DOI: 10.1093/cid/ciab189] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
Abstract
Background Tremendous progress towards elimination of trachoma as a public health problem has been made. However, there are areas where the clinical indicator of disease, trachomatous inflammation—follicular (TF), remains prevalent. We quantify the progress that has been made, and forecast how TF prevalence will evolve with current interventions. We also determine the probability that a district is a transmission-hotspot based on its TF prevalence (ie, reproduction number greater than one). Methods Data on trachoma prevalence come from the GET2020 global repository organized by the World Health Organization and the International Trachoma Initiative. Forecasts of TF prevalence and the percent of districts with local control is achieved by regressing the coefficients of a fitted exponential distribution for the year-by-year distribution of TF prevalence. The probability of a district being a transmission-hotspot is extrapolated from the residuals of the regression. Results Forecasts suggest that with current interventions, 96.5% of surveyed districts will have TF prevalence among children aged 1–9 years <5% by 2030 (95% CI: 86.6%–100.0%). Districts with TF prevalence < 20% appear unlikely to be transmission-hotspots. However, a district having TF prevalence of over 28% in 2016–2019 corresponds to at least 50% probability of being a transmission-hotspot. Conclusions Sustainable control of trachoma appears achievable. However there are transmission-hotspots that are not responding to annual mass drug administration of azithromycin and require enhanced treatment in order to reach local control.
Collapse
Affiliation(s)
- Seth Blumberg
- Francis I Proctor Foundation, University of California San Francisco, San Francisco, CA, USA.,Department of Medicine, University of California San Francisco, San Francisco, CA, USA
| | - Joaquin M Prada
- Faculty of Health and Medical Sciences, School of Veterinary Medicine, University of Surrey, Guildford, UK
| | - Christine Tedijanto
- Francis I Proctor Foundation, University of California San Francisco, San Francisco, CA, USA
| | - Michael S Deiner
- Francis I Proctor Foundation, University of California San Francisco, San Francisco, CA, USA
| | - William W Godwin
- Francis I Proctor Foundation, University of California San Francisco, San Francisco, CA, USA
| | - Paul M Emerson
- International Trachoma Initiative, The Task Force for Global Health, Decatur, Georgia, USA
| | - Pamela J Hooper
- International Trachoma Initiative, The Task Force for Global Health, Decatur, Georgia, USA
| | - Anna Borlase
- Nuffield Department of Medicine, Medical Sciences Division, University of Oxford, Oxford, UK
| | - T Deirdre Hollingsworth
- Nuffield Department of Medicine, Medical Sciences Division, University of Oxford, Oxford, UK
| | - Catherine E Oldenburg
- Francis I Proctor Foundation, University of California San Francisco, San Francisco, CA, USA.,Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.,Department of Ophthalmology, University of California San Francisco, San Francisco, CA, USA
| | - Travis C Porco
- Francis I Proctor Foundation, University of California San Francisco, San Francisco, CA, USA.,Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.,Department of Ophthalmology, University of California San Francisco, San Francisco, CA, USA
| | - Benjamin F Arnold
- Francis I Proctor Foundation, University of California San Francisco, San Francisco, CA, USA.,Department of Ophthalmology, University of California San Francisco, San Francisco, CA, USA
| | - Thomas M Lietman
- Francis I Proctor Foundation, University of California San Francisco, San Francisco, CA, USA.,Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.,Department of Ophthalmology, University of California San Francisco, San Francisco, CA, USA.,Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA
| |
Collapse
|
2
|
Kelly JD, Rebollo Polo M, Marie Zoure HG, Oldenburg CE, Keenan JD, Porco TC, Lietman TM. Assessing Onchocerciasis Subcriticality from Pre-Intervention Cross-Sectional Surveys. Am J Trop Med Hyg 2020; 103:287-294. [PMID: 32458796 PMCID: PMC7356432 DOI: 10.4269/ajtmh.19-0758] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Abstract
Elimination of an infectious disease requires subcritical transmission, or a reproductive number less than one, and can be assessed with cross-sectional surveys conducted by neglected tropical disease programs. Here, we assess the distribution of onchocerciasis prevalence taken from surveys across sub-Saharan Africa before the initiation of ivermectin in mass drug administrations. Pre-intervention nodular palpation cross-sectional surveys were available from 15 countries in the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) database. We determined whether the distribution of the prevalence over communities in an area was consistent with a geometric distribution, which previous studies have suggested indicates a subcritical disease. If not, we fitted a negative binominal distribution (hypothetically supercritical) or a mixture of two distributions: geometric (hypothetically subcritical) and Poisson (hypothetically supercritical). The overall distribution of community-level onchocerciasis prevalence estimates from the ESPEN dataset from 2005 to 2014 was not consistent with a geometric distribution. By contrast, data from several countries and parts of countries were consistent with the geometric distribution, for example, some areas within Nigeria and Angola. Even if the geometric distribution suggested pre-intervention subcriticality in more localized geographical areas, our model using pooled survey data of all geographic areas suggests that the entire pre-intervention prevalence does not fit a geometric distribution. Further work will be required to confirm the significance of a geometric distribution for onchocerciasis.
Collapse
Affiliation(s)
- John Daniel Kelly
- Institute for Global Health Sciences, UCSF, San Francisco, California.,Department of Epidemiology and Biostatistics, UCSF, San Francisco, California.,Francis I. Proctor Foundation, UCSF, San Francisco, California
| | - Maria Rebollo Polo
- Expanded Special Project for Elimination of Neglected Tropical Diseases, World Health Organization, Brazzaville, Republic of Congo
| | - Honorat Gustave Marie Zoure
- Expanded Special Project for Elimination of Neglected Tropical Diseases, World Health Organization, Brazzaville, Republic of Congo
| | - Catherine E Oldenburg
- Department of Ophthalmology, UCSF, San Francisco, California.,Department of Epidemiology and Biostatistics, UCSF, San Francisco, California.,Francis I. Proctor Foundation, UCSF, San Francisco, California
| | - Jeremy D Keenan
- Department of Ophthalmology, UCSF, San Francisco, California.,Francis I. Proctor Foundation, UCSF, San Francisco, California
| | - Travis C Porco
- Department of Ophthalmology, UCSF, San Francisco, California.,Department of Epidemiology and Biostatistics, UCSF, San Francisco, California.,Francis I. Proctor Foundation, UCSF, San Francisco, California
| | - Thomas M Lietman
- Department of Ophthalmology, UCSF, San Francisco, California.,Francis I. Proctor Foundation, UCSF, San Francisco, California.,Institute for Global Health Sciences, UCSF, San Francisco, California.,Department of Epidemiology and Biostatistics, UCSF, San Francisco, California
| |
Collapse
|